
Ebenezer O. Sackey
Examiner (ID: 17838)
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1613, 1201, 1626, 1624, 1621 |
| Total Applications | 2086 |
| Issued Applications | 1598 |
| Pending Applications | 91 |
| Abandoned Applications | 399 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9175044
[patent_doc_number] => 20130317029
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-28
[patent_title] => 'OXYPYRIMIDINES AS SYK MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 13/882958
[patent_app_country] => US
[patent_app_date] => 2011-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42329
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13882958
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/882958 | OXYPYRIMIDINES AS SYK MODULATORS | Oct 31, 2011 | Abandoned |
Array
(
[id] => 8240988
[patent_doc_number] => 20120149722
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-14
[patent_title] => 'HETEROARYL COMPOUNDS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/286062
[patent_app_country] => US
[patent_app_date] => 2011-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13947
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13286062
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/286062 | Heteroaryl compounds and uses thereof | Oct 30, 2011 | Issued |
Array
(
[id] => 9888995
[patent_doc_number] => 08975249
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-10
[patent_title] => 'Heterocyclic compounds and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 13/286061
[patent_app_country] => US
[patent_app_date] => 2011-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 22620
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13286061
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/286061 | Heterocyclic compounds and uses thereof | Oct 30, 2011 | Issued |
Array
(
[id] => 9192057
[patent_doc_number] => 20130331372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-12
[patent_title] => 'Cyclic Amine Substituted Oxazolidinone CETP Inhibitor'
[patent_app_type] => utility
[patent_app_number] => 13/881896
[patent_app_country] => US
[patent_app_date] => 2011-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60947
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13881896
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/881896 | Cyclic amine substituted oxazolidinone CETP inhibitor | Oct 24, 2011 | Issued |
Array
(
[id] => 10013855
[patent_doc_number] => 09056865
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-16
[patent_title] => 'Pyridine-2-derivatives as smoothened receptor modulators'
[patent_app_type] => utility
[patent_app_number] => 13/880298
[patent_app_country] => US
[patent_app_date] => 2011-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40319
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13880298
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/880298 | Pyridine-2-derivatives as smoothened receptor modulators | Oct 18, 2011 | Issued |
Array
(
[id] => 9055235
[patent_doc_number] => 20130252949
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-26
[patent_title] => 'APREPITANT L-PROLINE COMPOSITION AND COCRYSTAL'
[patent_app_type] => utility
[patent_app_number] => 13/825380
[patent_app_country] => US
[patent_app_date] => 2011-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 7996
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13825380
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/825380 | Aprepitant L-proline composition and cocrystal | Sep 22, 2011 | Issued |
Array
(
[id] => 7733915
[patent_doc_number] => 20120016122
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-19
[patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY'
[patent_app_type] => utility
[patent_app_number] => 13/241024
[patent_app_country] => US
[patent_app_date] => 2011-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 117725
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20120016122.pdf
[firstpage_image] =>[orig_patent_app_number] => 13241024
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/241024 | Compositions and methods for inhibition of the JAK pathway | Sep 21, 2011 | Issued |
Array
(
[id] => 8968864
[patent_doc_number] => 08507675
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-13
[patent_title] => 'Compositions and methods for inhibition of the JAK pathway'
[patent_app_type] => utility
[patent_app_number] => 13/241041
[patent_app_country] => US
[patent_app_date] => 2011-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 117712
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13241041
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/241041 | Compositions and methods for inhibition of the JAK pathway | Sep 21, 2011 | Issued |
Array
(
[id] => 7721072
[patent_doc_number] => 20120010407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-12
[patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY'
[patent_app_type] => utility
[patent_app_number] => 13/241037
[patent_app_country] => US
[patent_app_date] => 2011-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 117696
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20120010407.pdf
[firstpage_image] =>[orig_patent_app_number] => 13241037
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/241037 | Compositions and methods for inhibition of the JAK pathway | Sep 21, 2011 | Issued |
Array
(
[id] => 7721071
[patent_doc_number] => 20120010406
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-12
[patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY'
[patent_app_type] => utility
[patent_app_number] => 13/241036
[patent_app_country] => US
[patent_app_date] => 2011-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 117734
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20120010406.pdf
[firstpage_image] =>[orig_patent_app_number] => 13241036
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/241036 | Compositions and methods for inhibition of the JAK pathway | Sep 21, 2011 | Issued |
Array
(
[id] => 7721071
[patent_doc_number] => 20120010406
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-12
[patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY'
[patent_app_type] => utility
[patent_app_number] => 13/241036
[patent_app_country] => US
[patent_app_date] => 2011-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 117734
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20120010406.pdf
[firstpage_image] =>[orig_patent_app_number] => 13241036
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/241036 | Compositions and methods for inhibition of the JAK pathway | Sep 21, 2011 | Issued |
Array
(
[id] => 7670122
[patent_doc_number] => 20110319391
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-29
[patent_title] => 'METHODS AND COMPOSITIONS FOR STIMULATING NEUROGENESIS AND INHIBITING NEURONAL DEGENERATION'
[patent_app_type] => utility
[patent_app_number] => 13/231584
[patent_app_country] => US
[patent_app_date] => 2011-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15513
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13231584
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/231584 | Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration | Sep 12, 2011 | Issued |
Array
(
[id] => 9937481
[patent_doc_number] => 08987288
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-24
[patent_title] => 'Heterocyclic aminoberbamine derivatives, the preparation process and use thereof'
[patent_app_type] => utility
[patent_app_number] => 13/821667
[patent_app_country] => US
[patent_app_date] => 2011-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11737
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13821667
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/821667 | Heterocyclic aminoberbamine derivatives, the preparation process and use thereof | Sep 8, 2011 | Issued |
Array
(
[id] => 7818584
[patent_doc_number] => 20120065204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-15
[patent_title] => 'NOVEL N-HYDROXY-BENZAMIDS FOR THE TREATMENT OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/226567
[patent_app_country] => US
[patent_app_date] => 2011-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 25133
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20120065204.pdf
[firstpage_image] =>[orig_patent_app_number] => 13226567
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/226567 | N-hydroxy-benzamids for the treatment of cancer | Sep 6, 2011 | Issued |
Array
(
[id] => 7744467
[patent_doc_number] => 20120022068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-26
[patent_title] => 'NOVEL HETEROCYCLIC NF-kB INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/225144
[patent_app_country] => US
[patent_app_date] => 2011-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36921
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20120022068.pdf
[firstpage_image] =>[orig_patent_app_number] => 13225144
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/225144 | NOVEL HETEROCYCLIC NF-kB INHIBITORS | Sep 1, 2011 | Abandoned |
Array
(
[id] => 8549537
[patent_doc_number] => 08324420
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-04
[patent_title] => 'Process for producing acrylonitrile compound'
[patent_app_type] => utility
[patent_app_number] => 13/137584
[patent_app_country] => US
[patent_app_date] => 2011-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9090
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13137584
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/137584 | Process for producing acrylonitrile compound | Aug 25, 2011 | Issued |
Array
(
[id] => 9427697
[patent_doc_number] => 08703772
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-22
[patent_title] => 'Low hygroscopic aripiprazole drug substance and processes for the preparation thereof'
[patent_app_type] => utility
[patent_app_number] => 13/217636
[patent_app_country] => US
[patent_app_date] => 2011-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 23186
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13217636
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/217636 | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof | Aug 24, 2011 | Issued |
Array
(
[id] => 9153869
[patent_doc_number] => 08586775
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-11-19
[patent_title] => 'Therapeutic compounds and methods of use'
[patent_app_type] => utility
[patent_app_number] => 13/217127
[patent_app_country] => US
[patent_app_date] => 2011-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 27
[patent_no_of_words] => 8562
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13217127
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/217127 | Therapeutic compounds and methods of use | Aug 23, 2011 | Issued |
Array
(
[id] => 9239245
[patent_doc_number] => 08604037
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-10
[patent_title] => 'Therapeutic agents useful for treating pain'
[patent_app_type] => utility
[patent_app_number] => 13/212941
[patent_app_country] => US
[patent_app_date] => 2011-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 251943
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13212941
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/212941 | Therapeutic agents useful for treating pain | Aug 17, 2011 | Issued |
Array
(
[id] => 9004472
[patent_doc_number] => 20130225596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-29
[patent_title] => 'NOVEL HETEROCYCLIC DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME (AS AMENDED)'
[patent_app_type] => utility
[patent_app_number] => 13/816085
[patent_app_country] => US
[patent_app_date] => 2011-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 99975
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13816085
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/816085 | Heterocyclic derivative and pharmaceutical composition comprising the same | Aug 8, 2011 | Issued |